NCT00390793 2025-02-17Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.M.D. Anderson Cancer CenterPhase 2 Completed107 enrolled 11 charts